Genome-Edited Allogeneic CAR-T Cells: The Next Generation of Cancer Immunotherapies

0
51
The authors summarize the progress of universal allogeneic CAR-T cell therapies, addresses the critical challenges, and discusses the future directions for their clinical implementation.
[Journal of Hematology & Oncology]
Full Article